Summary Ecto-5'-nucleotidase (ecto-S'-NT) is a phosphatidylinositol anchored membrane structure recently defined as the lymphocyte differentiation antigen CD73. Using CD73 (I E9.28. 1) monoclonal antibody, normal mammary gland and breast carcinoma were immunohistochemically investigated for ecto-5'-NT expression. In normal breast epithelium, CD73 was differentially expressed in lobular, ductal and myoepithelial cells and was most frequently detected in the myoepithelial compartment. The glandular stroma contained fibrocytes, a subset of which was also CD73-positive. Among 102 unselected breast carcinoma primary lesions, only 9 contained CD73-positive tumour cells, whereas in 95 cases, stromal fibroblasts and fibrocytes showed variable degrees of CD73 expression. The extent of stromal CD73 expression correlated positively with the estrogen receptor (ER) status of the tumour (P < 0.038). We conclude that ecto-5'-NT-expression reflects a still unknown state of activity of normal breast epithelium which is lost in the majority of carcinomas derived therefrom. It may also be indicative of some functional activity of stromal fibroblasts which is significantly enhanced in ER-positive carcinomas.
Ecto-5'-nucleotidase (ecto-5'-NT) corresponds to the recently defined lymphocyte differentiation antigen CD73 (Thompson et al., 1990) . Ecto-5'-NT is a novel maturation marker for both T and B cells since the enzyme activity in peripheral blood T cells is approximately 10-fold higher than in thymocytes (Edwards et al., 1979) and since in adult peripheral B cells it is five-to six-fold higher than in foetal spleen or cord blood B cells (Thompson et al., 1986; Bastian et al., 1984) . Ecto-5'-NT is encoded on chromosome 6 (Boyle et al., 1988) and is a cell membrane associated enzyme of 69 kDa. In liver, placenta, and in lymphocytes, a substantial fraction of ecto-5'-NT activity can be released from membranes by the action of a phosphatidylinositol-specific phospholipase C, indicating the lack of a membrane-spanning segment and anchoring to the cell surface via a glycosyl phosphatidylinositol (GPI) moiety (Low & Finean, 1978; Thompson et al., , 1990 Bailyes et al., 1990; Misumi et al., 1990) . Monoclonal antibodies to a number of GPI-anchored lymphocyte differentiation antigens cause activation and proliferation (reviewed in Low, 1989) and recent experiments by Robinson et al. (1989) suggest that GPI anchors may be uniquely suited for transmembrane signal transduction.
Immunohistological investigations showed expression of CD73 antigen in the mantle-zone B-cells and follicular dendritic reticulum cells of the lymphoid tissue, in the endothelial cells of capillaries and venules, in the basal layer of nonkeratinising squamous epithelium and in the transitional cell type mucosa of the upper respiratory and urinary tract (Thompson et al., 1990) . In normal mammary gland CD73 antigen expression was found to be variable (Moller & Mielke, 1989 Clinico-pathological data of the patients Clinico-pathological characteristics of the 102 mammary carcinomas are shown in Table I . The hormone receptor status was biochemically determined by the dextran-coated charcoal (DCC) assay (Raam et al., 1982) . The threshold for positivity was 20 fmol mg-' protein. Menopausal status was taken from anamnestic data; for statistical analysis perimenopausal patients were regarded as 'not further defined'.
Histological tumour grading was classified according to Bloom and Richardson (Bloom & Richardson, 1957 (Thompson et al., 1989) 
Results
Normal and reactive mammary gland In normal non lactating breast tissue CD73 expression of cellular constituents was very variable, irrespective of the menopausal status. The ductal and acinar epithelium was predominantly CD73-negative, however, in some glands there were mostly small foci where these cells were faintly or strongly CD73-positive ( Figure 1) ; in addition the antigen could be detected inconsistently in myoepithelial cells and rarely in fibrocytes of the glandular stroma. There was no obvious association of epithelial CD73 expression and ductectasia or apocrine metaplasia or cyst formation, nor was it correlated with sclerosing adenosis. This CD73 distribution pattern could also be observed in non-neoplastic glandular remnants of the tumour tissues examined: lobular and ductal epithelium of the non-neoplastic tissue was negative in 80% of the carcinomas examined. It was CD73-positive in two out of 49 cases (4%). In 8/49 (16%) carcinomas the normal epithelium was mixed, negative and faintly CD73-positive. The myoepithelial compartment of the non-neoplastic tissue streptavidin-peroxidase complex was applied at a dilution of 1:100. All dilutions and washing steps were carried out in PBS. Tissue was incubated 1 h at room temperature with the primary antibody and 30 min with the second-and third-step reagents. Using 3-amino-9-ethylcarbazole (AEC) as the chromogen (0.4 mg ml-' in 0.1 M of acetate buffer pH 5.0 with 5% dimethylformamide (DMF) and 0.01% H202 for 10 min), the peroxidase reaction resulted in an intense red precipitate. The sections were counterstained with Harris' haematoxylin and mounted with glycerol gelatin. (Figure 2 ), four out of 102 (4%) contained both CD73-negative and -positive tumour cells and five out of 102 (5%) were weakly but entirely CD73-positive (Figure 4 ). Distorted and/or destroyed glandular remnants within the carcinomas were occasionally observed to express CD73 (e.g., Figure 2) ; however, the extent of CD73-positivity of this non-neoplastic compartment could not be exactly determined since it was not sufficiently well discernible as such from the carcinoma itself. Differences in the intensity of staining of myoepithelial cells in non-cancerous breast as compared to reactive myoepithelial remnants within cancerous lesions were not obvious.
The mode of CD73 expression in fibroblasts of the tumour stroma tended to be opposite to that of neoplastic cells. Seven out of 102 carcinomas (7%) had CD73-negative fibroblasts of the tumour stroma, whereas in 26 out of 102 carcinomas (25%), the fibroblast population was mixed with small numbers of negative and a majority of strongly CD73-positive cells (Figure 3; Figure 5 ). In 69 out of 102 tumours (68%) the fibroblast compartment was completely and strongly CD73-positive.
Statistical analysis revealed no correlation between the mode of CD73 expression of the glandular and myoepithelial compartment in non-neoplastic breast on the one hand and age or menopausal status on the other hand. The mode of CD73 expression within the carcinoma cell compartment was neither correlated with the patients' age or menopausal status nor with the hormone receptor status, histological tumour type, grade of differentiation or postoperative staging of the tumours. However, a significant positive correlation was found between CD73 antigen expression in the stromal fibroblasts and the biochemically determined ER status of the tumours (P<0.038).
Discussion
We have shown that the normal and fibrocystic state of the non-lactating mammarian gland is characterised by a variable CD73 expression in lobular and ductal epithelium and in the myoepithelial compartment. Reactive gland which could be detected in the vicinity of half of the tumour tissues examined showed a roughly corresponding pattern of CD73-positivity: ductal and acinar epithelial cells were positive in 20% of the cases; (subsets of) myoepithelial cells contained the antigen in 43%.
As compared to their normal counterparts, i.e., lobular and ductal epithelium, carcinoma cells expressed the antigen even more infrequently: only 9% of the cases were completely CD73-positive or contained variable amounts of CD73-positive tumour cells. This might be due to a loss of the capacity to express ecto-5'-NT upon stimuli yet to be defined. In contrast to the rare expression of CD73 antigen in tumour cells, the cells of the tumour stroma were completely CD73-positive in 68% and predominantly positive in 26% of the .,p -I 'I a , O'% a f.%y .
cases. The fibroblasts of the tumour stroma were completely CD73-negative in only 7% of carcinomas.
The functional role of ecto-5'-NT (CD73) in cellular components of normal and neoplastic breast tissue has not yet been defined. Ecto-5'-NT catalyses the extracellular dephosphorylation of purine and pyrimidine ribo-and deoxyribonucleotide monophosphates to the corresponding ribo-and deoxyribo-nucleosides (Naito & Lowenstein, 1981) . These compounds then may be transported inside the cell and reconverted to nucleotides via the purine salvage pathway. Thereby the enzyme can regulate the uptake of purines by converting non-transportable 5'-nucleotides (mainly adenosine monophosphates) into a transportable form (Shah et al., 1986; Thompson, 1985) .
In lymphocytes, it was shown that the catalytic activity of ecto-5'-NT can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells (Thompson, 1985) . Anti-5'-nucleotidase-IgG completely depressed cell proliferation, showing clearly that this is the only enzyme on the lymphocyte surface that is capable of degrading extracellular nucleotides (Andree et al., 1987) . Whether or not ecto-5'-NT may salvage extracellular nucleotides in breast tissue, however, is still unknown.
Ecto-5'-NT is thought to be a maturation marker for both T and B cells because of its significant higher enzyme activity in the peripheral lymphocytes than in immature precursor cells (Thompson et al., 1989) . Inhibition of ecto-5'-NT activity suppressed the proliferative and cytotoxic response of alloreactive T lymphocytes. These studies suggest a critical role of this cell surface enzyme in the functional maturation of both T and B lymphocytes (Massaia et al., 1988) . In addition, it was reported that substantial T cell proliferation can be induced when T lymphocytes are cultured for 3 days in the presence of CD73 monoclonal antibody 1E9.28.1 plus phorbol myristate acetate (PMA) and F(ab')2 goat antimouse IgG as a cross-linking reagent (Thompson, 1990) which indicates a possible agonistic effect of the monoclonal antibody to its receptor. Extending this knowledge of the functional role of ecto-5'-NT in lymphocytes to breast tissue cells, we conclude that CD73 antigen expression could be a sign of their maturation state and/or susceptibility to activation.
A number of tumour-cell produced substances are known to induce or act directly on the adjacent stroma cells (Dvorak, 1986; Martinez-Hernandez, 1988) . Tumours secrete substances such as tumour angiogenesis factor (Folkman, 1985) , which are capable of acting on vascular structures. The extracellular matrix secreted by human breast cancer cells has been shown to be mitogenic for fibroblasts (Kao et al., 1984) . Transforming growth factors (TGF alpha, TGF beta) are able to cause reversible phenotypic transformation of fibroblasts (Hsuan, 1989) . In hormone dependent MCF-7 breast cancer cells, oestrogen-induced growth factors were identified that may have a role in growth control and might act as oestrogen-induced 'second messengers' in oestrogen-responsive growth of human breast cancer (Dickson et al., 1986; Knabbe et al., 1987) . Our statistical analysis revealed an interdependence between the oestrogen receptor status of breast carcinomas and the ecto-5'-NT-expression of the adjacent stromal fibroblasts. Whether any of these effects of oestrogen-induced growth factors are mediated via CD73 will now have to be investigated. This study was supported by a grant of the Tumorzentrum Heidelberg/Mannheim.
